Projects per year
Search results
-
Finished
TAK-1 inhibition prevents cytokine-mediated CXCL12 production in a bone cancer cell line
McIntosh, K. (CoPI)
1/04/21 → 31/10/24
Project: Research - Studentship
-
Development and preclinical validation of novel PAR2 inhibitors for the treatment of Osteoarthritis
McIntosh, K. (Principal Investigator), Crilly, A. (Co-investigator), Jamieson, C. (Co-investigator), Plevin, R. (Co-investigator) & Rattray, Z. (Co-investigator)
1/04/20 → 30/09/22
Project: Research
-
Preventing the damaging effects of cancer chemotherapy and radiation treatment on human endothelial cells targeting the JNK pathway
Plevin, R. (Principal Investigator), Boyd, M. (Co-investigator) & McIntosh, K. (Co-investigator)
1/04/19 → 31/08/23
Project: Research - Studentship
-
Inhibition of human CXCL12 expression by novel inhibitory kappa B kinase alpha compounds - a novel approach for new drug development in breast cancer
McIntosh, K. (Principal Investigator) & Patton, C. (Post Grad Student)
8/10/18 → 31/12/21
Project: Internally funded project
-
Investigating the role of the non-canconical arm of the NFkB pathway in pancreatic cancer, utilising novel inhibitory compounds.
McIntosh, K. (Principal Investigator)
1/10/18 → 2/09/19
Project: Internally funded project
-
Preclinical validation of novel PAR-2 inhibitors for the treatment of Osteoarthritis and Cancer
McIntosh, K. (Research Co-investigator) & Plevin, R. (Principal Investigator)
1/02/14 → 30/09/15
Project: Research
-
Evaluation of novel PAR-2 inhibitors in cellular proliferation. Summer Student Placement Project (£1,600). Professor Robin Plevin and Dr Kathryn McIntosh
McIntosh, K. (Principal Investigator) & Plevin, R. (Principal Investigator)
27/05/13 → 27/09/13
Project: Research
-
Purinergic regulation of JNK signalling in cancer cells - novel modulation of proliferative capacity by GPCRs. (£1,850)
McIntosh, K. (Principal Investigator) & Plevin, R. (Principal Investigator)
27/05/13 → 27/09/13
Project: Research